Alexander Solms
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.
Journal: Drugs in R&D
Published: October 25, 2024
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.
Journal: Drugs in R&D
Published: July 18, 2024
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 14, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
Journal: Kidney international
Published: October 20, 2023
Evaluation of covariate effects in item response theory models.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 13, 2023
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches.
Journal: Clinical pharmacokinetics
Published: June 25, 2023
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis.
Journal: Drugs in R&D
Published: May 28, 2023
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective.
Journal: Clinical pharmacology and therapeutics
Published: November 22, 2022
Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81-8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting.
Journal: BMC medical research methodology
Published: December 10, 2021
PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 22, 2021
Optimising prophylaxis in haemophilia A: The ups and downs of treatment.
Journal: Blood reviews
Published: November 27, 2020
Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin.
Journal: Pharmaceutical research
Published: September 04, 2020
Last Updated: 09/26/2026